SearcharxivSearch

arXiv subjects

Kourosh Saeb-Parsy

Publications and source records attributed to Kourosh Saeb-Parsy.

2 recordsLinked to original sources

Integrative Adaptive Indexes from Noisy Routine Haematological Markers can Predict and Discriminate Health Status and Biological Age

For more than two decades, advances in personalised medicine and precision healthcare have largely been based on genomics and other omics data. These strategies aim to tailor interventions to individual patient profiles, promising greater treatment efficacy and more efficient allocation of healthcare resources. Here, we show that widely collected common haematologic markers can reliably predict and discriminate individual chronological age and health status from even noisy sources. Our analysis includes synthetic and real retrospective patient data, including medically relevant and extreme cases, and draws on more than 100\,000 complete blood count records over 13 years from the United States Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey (CDC NHANES). We combine fully explainable risk assessment scores with machine and deep learning techniques to focus on clinically significant patterns and characteristics without functioning purely as a ''black-box model allowing interpretation and control. We validated the results with the UK Biobank, a larger cohort independent of the CDC NHANES and with very different collection techniques, the former a survey and the second a longitudinal study. Unlike current biological ageing indicators, this approach may offer rapid, and scalable implementations of personalised, precision and predictive approaches to healthcare and medicine without or before requiring other specialised, uncommon or costly tests.

q-bio.QM

The Human Cell Atlas White Paper

The Human Cell Atlas (HCA) will be made up of comprehensive reference maps of all human cells - the fundamental units of life - as a basis for understanding fundamental human biological processes and diagnosing, monitoring, and treating disease. It will help scientists understand how genetic variants impact disease risk, define drug toxicities, discover better therapies, and advance regenerative medicine. A resource of such ambition and scale should be built in stages, increasing in size, breadth, and resolution as technologies develop and understanding deepens. We will therefore pursue Phase 1 as a suite of flagship projects in key tissues, systems, and organs. We will bring together experts in biology, medicine, genomics, technology development and computation (including data analysis, software engineering, and visualization). We will also need standardized experimental and computational methods that will allow us to compare diverse cell and tissue types - and samples across human communities - in consistent ways, ensuring that the resulting resource is truly global. This document, the first version of the HCA White Paper, was written by experts in the field with feedback and suggestions from the HCA community, gathered during recent international meetings. The White Paper, released at the close of this yearlong planning process, will be a living document that evolves as the HCA community provides additional feedback, as technological and computational advances are made, and as lessons are learned during the construction of the atlas.

q-bio.TO